HIV-1 gp41: Role in HIV entry and prevention

Immunobiology

Volumn 201, Issue 3-4, 2000, Pages 308-316

  Chen, Ying Hua ^a   Xiao, Yi ^a   Dierich, Manfred P ^b  

^a TSINGHUA UNIVERSITY   (China)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS GLYCOPROTEIN;

AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; TARGET CELL; VIRUS CELL INTERACTION;

EID: 0033965256     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80085-6     Document Type: Article

References (56)

1. DALGLEISH, A. G., P. C. L. BEVERLEY, P. R. CLAPHAM, D. H. DRAWFORD, M. F. GREAVERS, R. A. WEISS. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-767.
2. FENG, Y., C. C. BRODER, P. E. KENNEDY, E. A. BERGER. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
3. DRAGIC, T., V. LITWIN, G. P. ALLAWAY, S. R. MARTIN, Y. HUANG, K. A. NAGASHIMA, C. CAYANAN, P. J. MADDON, R. A. KOUP, J. P. MOORE, W. A. PAXTON. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381: 667-673.
4. BINLEY, J., J. P. MOORE. 1997. The viral mousetrap. Nature 387: 346-348.
5. CHEN, Y. H., C. EBENBICHLER, R. VORNHAGEN, T. F. SCHULZ, G. BÖCK, F. STEINDL, H. KATINGER, M. P. DIERICH. 1992. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9. AIDS 6: 533-539.
6. CHEN, Y. H., A. CHRISTIANSEN, G. BÖCK, M. P. DIERICH. 1995. HIV-2 transmembrane protein gp36 like HIV-1 gp41 binds to human lymphocytes and monocytes. AIDS 9: 1193-1994.
7. HENDERSON, L. A., M. N. QURESHI. 1993. A peptide inhibitor of human immunodeficence virus infection binds to novel human cell surface polypeptides. J. Biol. Chem. 268: 15291-15287.
8. EBENBICHLER, C., C. RODER, R. VORNHAGEN, R. RATNER, M. P. DIERICH. 1993. Cell surface proteins binding to recombinant soluble HIV-1 and HIV-2 transmembrane proteins. AIDS 7: 489-492.
9. WEISSENHORN, W., A. DESSEN, S. C. HARRISON, J. J. SKEHEL, D. C. WILEY. 1997. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387: 426-430.
10. CHAN, D. C., D. FASS, J. M. BERGER, P. S. KIM. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89: 263-273.
11. SHAFFERMAN, A., P. B. JAHRLING, R. E. BENVENISTE. 1991. Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc. Natl. Acad. Sci. USA 88: 7126-7130.
12. LEWIS, M. G., W. R. ELKINS,. F. E. MCCUTCHAN. 1993. Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine. 11: 1347-1352.
13. CHEN, Y. H., M. P. DIERICH. 1998. A common epitope on gp41, IFN-α and -β induces protective activity. Immunology Today. 19: 586-587.
14. LACASSE, R. A., K. E. FOLLIS, M. TRAHEY, J. D. SCARBOROUGH, D. R. LITTMAN, J. H. NUNBERG. 1999. Fusion-competent vaccines: broad neutralization of primary isolates of HIV. Science 283: 357-362.
15. MONTEFIORI, D. C., J. P. MOORE. 1991. HIV vaccines: magic of the occult? Science 283: 336-337.
16. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, M. P. DIERICH. 1993. HIV-1 gp41 binding to human periphal blood mononuclear cells occurs preferentially to B lymphocytes and monocytes. Immunobiology 188: 323-329.
17. CHEN, Y. H., M. P. DIERICH. 1996. Identification of a second site in HIV-1 gp41 mediating binding to cells. Immnunol. Letters 52: 153-156.
18. CHEINGSONG-POPOV R., C. PANAGIOTIDI, K. CAUN. 1990. Antibodies to a putative HIV gp 41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection. AIDS 4: 251-253.
19. QURESHI, N. M., D. H. COY, R. F. CARRY, L. A. HENDERSON. 1990. Characterization of a putative cellular receptor for HIV-1 transmembrane glycoprotein using synthetic peptides. AIDS 4: 553-558.
20. DENNER, J., T. VOGEL, S. NORLET, J. ENNER, R. KURTH. 1994. The immunosuppressive (ISU-) peptide of HIV-1: Binding proteins on lymphocytes detected by different methods. J. Can. Res. Clin. Oncol. 121: S35.
21. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, M. P. DIERICH. 1993. HIV-1 gp41 binds to several proteins on the human B cell line, Raji. Mol. Immunol. 30: 1159-1163.
22. CHEN, Y. H., M. P. DIERICH. 1998. Biological function of HIV-1 transmembrane protein gp41 - A Study on a putative cellular receptor of gp41. Chinese Science Bulletin 43: 1630-1634.
23. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, M. P. DIERICH. 1993. The human monocytes cell line U937 by proteins of 37, 45, 49, 62 and 92kD binds HIV-1 gp41. Immunol. Letters 37: 41-45.
24. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, M. P. DIERICH. 1994. HIV-1 gp41 binding proteins and antibodies to gp41 could inhibit enhancement of human Raji cell MHC class I and II antigen expression by gp41. Mol. Immunol. 31: 977-982.
25. CHEN, Y. H., G. BÖCK, R. VORNHAGEN, F. STEINDL, H. KATINGER, M. P. DIERICH. 1994. HIV-1 gp41 like interferons enhances MHC class land ICAM-1 expression on H9 and U937 cells. Intern. Arch. Allergy Immunol. 104: 227-231.
26. CHEN, Y. H., Y. XIAO, W. WU, J. YANG, S. SUI, M. P. DIERICH. 1999. The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62. AIDS 13: 1021-1024.
27. CHOWDHURY, I. H., Y. KOYANAGI, S. KOBAYASHI. 1990. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway. Virology 176: 126-132.
28. CHEN, Y. H., A. CHRISTIANSEN, M. P. DIERICH. 1996. HIV-1 gp41 binding to human T and B-lymphocytes and monocytes is modulated by phorbol myristate acetate. Immunol. Letters 50: 161-166.
29. JIANG, S., K. LIN, N. STRICK. 1993. HIV-1 inhibition by a peptide. Nature 365: 113.
30. DENNER, J., S. NORLET, R. KURTH. 1994. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients. AIDS 8: 1063-1072.
31. MUSTER, T. H., F. STEINDL, M. PURTSCHER, A. TRKOLA, A. KLIMA, G. HIMMLER, F. RUKER, H. KATINGER. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virology 67: 6642-6647.
32. MCCUNE, J. M., L. B. RABIN, M. B. FEINBERG. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 53: 55-67.
33. NEURATH, A. R., K. LIN, S. JIANG. 1995. Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain. AIDS Research and Human Retroviruses 11: 189-190.
34. FURUTA, R. A., C. T. WILD, Y. WENG, C. D. WEISS. 1998. Capture of an early fusion-active conformation of HIV-1 gp41. Nature Structural Biology 5: 276-279.
35. CHAN, D. C., P. S. KIM. 1998. HIV entry and its inhibition. Cell 93: 681-684.
36. JONES, P. L., J. T. KORTE, R. BLUMENTHAL. 1998. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273: 404-409.
37. HUGHSON, F. M. 1997. Enveloped viruses: a common mode of membrane fusion? Current Biology 7: R565-R569.
38. MUNOZ-BARROSO, I., S. DURELL, K. SAKAGUCHI. 1998. Dilation of the human immuno-deficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biology 140: 315-323.
39. CALLEBAUT, C., J. BLANCO, N. BENKIRANE. 1998. Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4+ cells. J. Biol. Chem. 273: 21988-21997.
40. CHEN, Y. H., A. CHRISTIANSEN, M. P. DIERICH. 1995. HIV-1 gp41 selectively inhibits spontaneous cell proliferation of human cell lines and mitogen-and recall antigen-induced lymphocyte proliferation. Immunol. Letters 48: 39-44.
41. CIANCIOLO, G. J., R. J. KIPNIS, R. SNYDERMAN. 1984. Similarity between p15E of murine and feline leukemia viruses and p21 of HTLV. Nature 311: 515-520.
42. RUEGG, C. L., M. STRAND. 1990. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J. Immunol. 144: 3928-3935.
43. RUEGG, C. L., M. STRAND. 1991. A synthetic peptide with sequence identity to the membrane proteins gp41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cellular Immunol. 1137: 1-13.
44. CHEN, Y. H., Y. XIAO, W. WU, Y. X. ZHAO, S. CORNELIA, M. P. DIERICH. 1997. The immunosuppressive peptide of HIV-1 gp41 like human type I interferons up-regulates MHC class I expression on H9 and U937 cells. Immunol Letters 59: 93-97.
45. SU, S. B., J. L. GAO, W. H. GONG, N. M. DUNLOP, P. M. MURPHY, J. J. OPPENHEIM, J. M. WANG. 1999. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocyes by using G-protein-coupled formyl peptide receptors. J. Immunol. 162: 5924-5930.
46. SU, S. B., W. H. GONG, J. L. GAO, W. P. SHEN, M. C. GRIMM, X. DENG, P. M. MURPHY, J. J. OPPENHEIM, J. M. WANG. 1999. T20/DP178, an ectodomain peptide of human immunodeficiency virus tupe 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93: 3885-3892.
47. FISH, E. N. 1992. Definition of receptor binding domains in the interferon-α. J. Interf. Res. 12: 257-266.
48. CHEN, Y. H., H. STOIBER, M. P. DIERICH. 1997. Increased level of antibodies against interferon-α in HIV-1 positive individuals may be explained by a common immunological epitope on the human interferon-α and HIV-1 gp41. Immunol. Letters 55: 15-18.
49. CHEN, Y. H., J. N. FENG, G. STOCKL, K. HU, M. P. DIERICH. 1997. HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-β in HIV-1 positive individuals. Mol. Immnuol. 34: 1259-1262.
50. CHEN, Y. H., M. P. DIERICH. 1998. A common immunological epitope existing between HIV-1 gp41 and human interferon-α and -β. Immunobiology 198: 333-342.
51. GRINGERI, A., E. SANTAGOSTINO, P. M. MANNUCCI. 1994. A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFNa immunization. J. Acquir. Immune. Defic. Syndr. 7: 978-988.
52. PURTSCHER, M., A. TRKOLA, G. GRUBER, A. BUCHACHER, R. PREDL, F. STEINDL, C. TAUER, R. BERGER, N. BARRETT, A. JUNGBAUER, H. KATINGER. 1994. A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1. AIDS Res. Human Retroviruses 10: 1651-1657.
53. SHIBATA, R., T. IGARASHI, N. HAIGWOOD. 1999. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nature Medicine 5: 204-210.
54. IGARASHI, T., C. BROWN, A. AZADEGAN, N. HAIGWOOD, D. DIMITROV, M. A. MARTIN & R. SHIBATA. 1999. Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nature Med. 5: 211-216.
55. CONNOR, R. I., B. T. M. KORBER, B. S. GRAHAM, B. H. HAHN, D. D. HO, B. D. WALKER, A. U. NEUMANN, S. H. VERMUND, J. MESTECKY, S. JACKSON, ET AL. 1998. Immunological and Virological Analyses of Persons Infected by Human-Immunodeficiency-Virus Type-1 While Participating in Trials of Recombinant gp120 Subunit Vaccines. J. Virol. 72: 1552-1576.
56. MOORE, J. P., D. R. NURTON. 1999. HIV-1 neutralizing antibodies: How full is the bottle? Nature Medicine 5: 142-144.